MedTrace Logo

Dealcoholized Muscadine Wine and Skin Health in Women

NCT04614753 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-06-12

No results posted yet for this study

Summary

The objective of this clinical trial is to determine the activity of dealcoholized muscadine wine to alleviate oxidative stress, inflammation, skin photoaging, and alter gut microbiome in women 40-67 years of age. The investigators hypothesize that dealcoholized muscadine wine daily for 42 days will significantly alleviate oxidative stress, inflammation, skin photoaging, and alter the gut microbiome in women compared to drinking sugar water.

Conditions

  • Skin Health

Interventions

OTHER

Dealcoholized Muscadine Wine

300 ml of Dealcoholized Muscadine Wine

OTHER

Control Beverage

300ml of Sugar Water and Acid Content

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Liwei Gu, PhD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
67 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-10
Primary Completion
2024-10-07
Completion
2024-10-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04614753 on ClinicalTrials.gov